Abstract
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal, neurodegenerative disease of the human motor system. The pathogenesis of ALS is a topic of fascinating speculation and experimentation, with theories revolving around intracellular protein inclusions, mitochondrial structural issues, glutamate excitotoxicity and free radical formation. This review explores the rationale for the involvement of a novel protein, B-cell lymphoma/leukaemia 11b (Bcl11b) in ALS. Bcl11b is a multifunctional zinc finger protein transcription factor. It functions as both a transactivator and genetic suppressor, acting both directly, binding to promoter regions, and indirectly, binding to promoter-bound transcription factors. It has essential roles in the differentiation and growth of various cells in the central nervous system, immune system, integumentary system and cardiovascular system, to the extent that Bcl11b knockout mice are incompatible with extra-uterine life. It also has various roles in pathology including the suppression of latent retroviruses, thymic tumourigenesis and neurodegeneration. In particular its functions in neurodevelopment, viral latency and T-cell development suggest potential roles in ALS pathology.
Similar content being viewed by others
References
Abbas S, Sanders MA, Zeilemaker A, Geertsma-Kleinekoort WMC, Koenders JE, Kavelaars FG, Abbas ZG, Mahamoud S, Chu IW, Hoogenboezem R, Peeters JK, van Drunen E, van Galen J, Beverloo HB, Löwenberg B, Valk PJM (2014) Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations. Haematologica 99(5):848–857. doi:10.3324/haematol.2013.095604
Alfahad T, Nath A (2013) Retroviruses and amyotrophic lateral sclerosis. Antiviral Res 99(2):180–187. doi:10.1016/j.antiviral.2013.05.006
Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, Garson JA (2000) Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. J Med Virol 61(4):527–532. doi:10.1002/1096-9071(200008)61:4<527:AID-JMV17>3.0.CO;2-A
Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, MacKlis JD (2005) Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45:207–221. doi:10.1016/j.neuron.2004.12.036
Beers DR, Henkel JS, Zhao W, Wang J, Appel SH (2008) CD4 + T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA 105(40):15558–15563. doi:10.1073/pnas.0807419105
Betancourt J, Katzman S, Chen B (2014) Nuclear factor one B regulates neural stem cell differentiation and axonal projection of corticofugal neurons. J Comp Neurol 522:6–35. doi:10.1002/cne.23373
Bock M, Stoye JP (2000) Endogenous retroviruses and the human germline. Curr Opin Genet Dev 10(6):651–655. doi:10.1016/S0959-437X(00)00138-6
Canovas J, Berndt FA, Sepulveda H, Aguilar R, Veloso FA, Montecino M, Oliva C, Maass JC, Sierralta J, Kukuljan M (2015) The specification of cortical subcerebral projection neurons depends on the direct repression of TBR1 by CTIP1/BCL11a. J Neurosci 35(19):7552–7564. doi:10.1523/JNEUROSCI.0169-15.2015
Chen J, Magavi SSP, Macklis JD (2004) Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. Proc Natl Acad Sci USA 101(46):16357–16362. doi:10.1073/pnas.0406795101
Chen B, Wang SS, Hattox AM, Rayburn H, Nelson SB, McConnell SK (2008) The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Natl Acad Sci USA 105(32):11382–11387. doi:10.1073/pnas.0804918105
Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O (2013) CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci USA 110(31):12655–12660. doi:10.1073/pnas.1220136110
Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, Brown RH Jr, Carroll MC (2008) T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA 105(46):17913–17918. doi:10.1073/pnas.0804610105
Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D (2005) BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene 24:6753–6764. doi:10.1038/sj.onc.1208904
Cismasiu VB, Paskaleva E, Suman Daya S, Canki M, Duus K, Avram D (2008) BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 380:173–181. doi:10.1016/j.virol.2008.07.035
Cluskey S, Ramsden DB (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol 54(6):386–392. doi:10.1136/mp.54.6.386
Daoud H, Valdmanis PN, Gros-Louis F, Belzil V, Spiegelman D, Henrion E, Diallo O, Desjarlais A, Gauthier J, Camu W, Dion PA, Rouleau GA (2011) Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68(5):587–593. doi:10.1001/archneurol.2010.351
Desplats PA, Lambert JR, Thomas EA (2008) Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington’s disease. Neurobiol Dis 31:298–308. doi:10.1016/j.nbd.2008.05.005
Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80(15):1415–1423. doi:10.1212/WNL.0b013e31828c2e9e
Doetsch F, García-Verdugo JM, Alvarez-Buylla A (1997) Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 17(13):5046–5061
Donaghy C, Dick A, Hardiman O, Patterson V (2008) Timeliness of diagnosis in motor neurone disease: a population-based study. Ulster Med J 77(1):18–21
Enomoto T, Ohmoto M, Iwata T, Uno A, Saitou M, Yamaguchi T, Kominami R, Matsumoto I, Hirota J (2011) Bcl11b/Ctip2 controls the differentiation of vomeronasal sensory neurons in mice. J Neurosci 31(28):10159–10173. doi:10.1523/JNEUROSCI.1245-11.2011
Fame R, MacDonald J, Macklis J (2012) Development, specification, and diversity of callosal projection neurons. Trends Neurosci 29(6):997–1003. doi:10.1016/j.biotechadv.2011.08.021.Secreted
Henkel JS, Beers DR, Zhao W, Appel sh (2009) Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 4(4):389–398. doi:10.1007/s11481-009-9171-5
Huang X, Du X, Li Y (2012) The role of BCL11B in hematological malignancy. Exp Hematol Oncol 1(1):22. doi:10.1186/2162-3619-1-22
Kato H, Horikoshi M, Roeder RG (1991) Repression of HIV-1 transcription by a cellular protein. Science 251(5000):1476–1479
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942–955. doi:10.1016/S0140-6736(10)61156-7
Kolson D, Gonzalez-Scarano F (2001) Endogenous retroviruses and multiple sclerosis. Ann Neurol 50(4):429–430
Kominami R (2012) Role of the transcription factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser B 88(3):72–87. doi:10.2183/pjab.88.72
Le Douce V, Cherrier T, Riclet R, Rohr O, Schwartz C (2014) CTIP2, a multifunctional protein: cellular physiopathology and therapeutic implications. Med Sci 30(8–9):797–802. doi:10.1051/medsci/20143008019
Lewis C-A, Manning J, Rossi F, Krieger C (2012) The neuroinflammatory response in ALS: the roles of microglia and T cells. Neurol Res Int 2012:1–8. doi:10.1155/2012/803701
Li W, Jin Y, Prazak L, Hammell M, Dubnau J (2012) Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One 7(9):1–10. doi:10.1371/journal.pone.0044099
Li W, Lee M, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A (2015) Human endogenous retrovirus-K contributes to motor neuron disease. Science Translational Medicine 7(307):307ra153. doi:10.1126/scitranslmed.aac8201
Liu P, Li P, Burke S (2010) Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol Rev 238(1):138–149. doi:10.1111/j.1600-065X.2010.00953.x
Lodato S, Molyneaux BJ, Zuccaro E, Goff LA, Chen H-H, Yuan W, Meleski A, Takahashi E, Mahony S, Rinn JL, Gifford DK, Arlotta P (2014) Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons. Nat Neurosci 17(8):1046–1054. doi:10.1038/nn.3757
Löwer R (1999) The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol 7(9):350–356. doi:10.1016/S0966-842X(99)01565-6
MacGowan DJL, Scelsa SN, Imperato TE, Liu K-N, Baron P, Polsky B (2007) A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68(22):1944–1946. doi:10.1212/01.wnl.0000263188.77797.99
Marban C, Redel L, Suzanne S, Van Lint C, Lecestre D, Chasserot-Golaz S, Leid M, Aunis D, Schaeffer E, Rohr O (2005) COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res 33(7):2318–2331. doi:10.1093/nar/gki529
Mitchell JD, Borasio GD (2007) Amyotrophic lateral sclerosis. Lancet 369:2031–2041. doi:10.1016/S0140-6736(07)60944-1
Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W (2001) Reversible ALS-like disorder in HIV infection. Neurology 57(6):995–1001. doi:10.1212/WNL.57.6.995
Ou SH, Wu F, Harrich D, García-Martínez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69(6):3584–3596
Pan YW, Storm DR, Xia Z (2013) Role of adult neurogenesis in hippocampus-dependent memory, contextual fear extinction and remote contextual memory: new insights from ERK5 MAP kinase. Neurobiol Learn Mem 105:81–92. doi:10.1016/j.nlm.2013.07.011
Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10(3):253–263. doi:10.1016/S1474-4422(11)70015-1
Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJS (2001) The BCL11 gene family : involvement of BCL11A in lymphoid malignancies. Blood 98(12):3413–3420. doi:10.1182/blood.V98.12.3413
Simon R, Brylka H, Schwegler H, Venkataramanappa S, Andratschke J, Wiegreffe C, Liu P, Fuchs E, Jenkins NA, Copeland NG, Birchmeier C, Britsch S (2012) A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis. EMBO J 31(13):2922–2936. doi:10.1038/emboj.2012.142
Tang B, Di Lena P, Schaffer L, Head SR, Baldi P, Thomas EA (2011) Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling. PLoS One. doi:10.1371/journal.pone.0023691
Verma A, Berger JR (2006) ALS syndrome in patients with HIV-1 infection. J Neurol Sci 240(1–2):59–64. doi:10.1016/j.jns.2005.09.005
Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G (2007) Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol 14(3):262–268. doi:10.1111/j.1468-1331.2006.01575.x
Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews. Neurology 5(6):311–322. doi:10.1038/nrneurol.2009.54
Acknowledgments
The authors acknowledge the generous support and funding of the Peter Duncan Neurosciences Research Unit for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Lennon, M.J., Jones, S.P., Lovelace, M.D. et al. Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?. Neurotox Res 29, 201–207 (2016). https://doi.org/10.1007/s12640-015-9573-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-015-9573-5